• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
    All News #Library

    Trump`s tariffs reveal India`s drug safety issue

    #N/A

    ENHERTU® Phase 3 Trial Begins for HER2+ Advanced Gastric Cancer

    BUSINESSWIRE

    Corcept`s Phase 3 trial meets primary endpoint in ovarian cancer

    BUSINESSWIRE

    DKSH Technology acquires Korean life science firm MDxK

    PRESS RELEASE

    US FDA approves freeze-dried version of Bavarian Nordic vaccine

    REUTERS

    US judge rejects J&J`s $10 billion baby powder settlement

    REUTERS

    AZ`s Imfinzi wins perioperative FDA nod in bladder cancer

    FIERCE PHARMA

    Merck`s Winrevair cuts death, morbidity risk by 76%

    FIERCE PHARMA

    BiomX’s phage therapy succeeds in Ph 2 diabetic bone study

    ENDPTS

    Lilly drug cuts genetic heart disease risk factor by 94% in trial

    REUTERS

    Sensorion to Hold French Webconference for Retail Shareholders

    BUSINESSWIRE

    GE HealthCare Acquires Nihon Medi-Physics, Radiopharma Company

    BUSINESSWIRE

    Sphere Bio launches Cyto-Cellect IgG Kappa and Viability Assay Kit

    BUSINESSWIRE

    Ideagen excels in G2 Spring 2025 with 82 badges, 31 top rankings

    BUSINESSWIRE

    BeiGene gets CHMP nod for TEVIMBRA for Lung Cancer

    BUSINESSWIRE

    Exact Sciences Launches Cologuard Plus™ Test for Cancer Screening

    BUSINESSWIRE

    SK Capital Makes Strategic Investment in Spectrum Vascular

    BUSINESSWIRE

    ICON plc Schedules First Quarter 2025 Earnings Conference Call

    BUSINESSWIRE

    Experts Prioritize International Collab in Pulmonary Hypertension

    BUSINESSWIRE

    Seaport Therapeutics to Join Investor Conferences in April

    BUSINESSWIRE

    Kairos Pharma Ltd. Completes Safety Arm of ENV105 Trial

    BUSINESSWIRE

    KalVista Pharmaceuticals at 24th Annual Needham Healthcare Confer

    BUSINESSWIRE

    Adicet Bio to Join 2025 Canaccord Genuity Oncology Conference

    BUSINESSWIRE

    Japan Tobacco & D-Wave`s Quantum Proof-of-Concept Outperform Results

    BUSINESSWIRE

    Ionis to present at upcoming investor conferences

    BUSINESSWIRE

    OS Therapies Update on Rare Pediatric Cancer Immunotherapy OST-HER2

    BUSINESSWIRE

    Tenpoint Therapeutics to Join Investor Conferences in April

    BUSINESSWIRE

    Enveric Biosciences Reports Financial Results for Fiscal Year 2024

    BUSINESSWIRE

    ENDRA Life Sciences Enhances Strategy for Disease Detection

    BUSINESSWIRE

    Alpha Cognition Reports Q4 and Full Year 2024 Financials

    BUSINESSWIRE

    USAntibiotics Names Mark Tengler Senior VP of Manufacturing Tech

    BUSINESSWIRE

    Forte Biosciences Updates on Results and Clinical Progress

    BUSINESSWIRE

    Otsuka Files BLA for Sibeprenlimab in Immunoglobulin A Nephropathy

    BUSINESSWIRE

    Cycle Vita™ adds BAFIERTAM® for Multiple Sclerosis support

    BUSINESSWIRE

    bioAffinity Technologies Reports $9.4M Revenue in 2024

    BUSINESSWIRE

    Rite Aid Shares Allergy Season Tips to Ease Symptoms

    BUSINESSWIRE

    LucyRx Unveils Brand Identity to Champion Patient Care

    BUSINESSWIRE

    Science Exchange Acquires HappiLabs for Procurement Expansion

    BUSINESSWIRE

    Lynch Regenerative Medicine Acquires REGRANEX Gel & Exclusive Right

    BUSINESSWIRE

    ACC: Low-Dose Colchicine Reduces Coronary Plaque Progression

    BUSINESSWIRE

    AZD0780, oral inhibitor, reduces LDL-C in PURSUIT Phase IIb Trial

    BUSINESSWIRE

    Nexus Pharmaceuticals Launches Fluorescein 2 mL

    BUSINESSWIRE

    Omeros Corporation Reports 2024 Financial Results

    BUSINESSWIRE

    Circle Pharma to Present at the Upcoming Investor Conferences

    BUSINESSWIRE

    Travere Therapeutics to Present New FILSPARI® Data at NKF Spring

    BUSINESSWIRE

    OS Therapies Reports 2024 Financial Results and Business Update

    BUSINESSWIRE

    Geron to Announce Q1 2025 Financial Results on May 7, 2025

    BUSINESSWIRE

    Adicet Bio Reports Inducement Grants Under Nasdaq Rule 5635(c)(4)

    BUSINESSWIRE

    Sarepta Announces Inducement Grants Under Nasdaq LR 5635(c)(4)

    BUSINESSWIRE

    Navidea Biopharmaceuticals extends plan to protect tax assets

    BUSINESSWIRE

    Johnson & Johnson to Defeat Talc Claims in Tort System

    BUSINESSWIRE

    SINOVAC Announces Decision to Declare Cash Dividend

    BUSINESSWIRE

    SPARC submits IND application for SBO-154 to USFDA

    #N/A

    USC-licensed startup NeOnc Technologies gets NASDAQ listing

    #N/A

    HRV Global Life Sciences delivers Indian anti-diabetic drugs

    #N/A

    LuNGS Alliance offers free lung NGS testing for Indian cancer pat

    #N/A

    IDEAYA Bio gets FDA Breakthrough for Darovasertib in Uvea Melanoma

    PR NEWSWIRE

    Theravance Biopharma to Join Investor Conference

    PR NEWSWIRE

    Harbour BioMed Reports Full Year 2024 Financial Results

    PR NEWSWIRE

    HAS Healthcare acquires Cerbios-Pharma to form CDMO Group

    PR NEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.